Why did Nvidia reach $4 trillion market cap?
How are Trump's tariffs impacting copper prices?
What led to Linda Yaccarino stepping down at X?
Why was the FTC 'click-to-cancel' rule blocked?
How will rising student loan payments affect borrowers?
What caused Revolut's valuation to jump to $65B?
How is AI reshaping advertising at WPP?
Rhythm Pharma's Oral Drug For Rare Obesity Shows Promise
benzinga.com/news/health-care/25/07/46327353/rhythm-pharmas-oral-drug-for-rare-obesity-shows-promise
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) on Wednesday released topline results from its Phase 2 trial evaluating bivamelagon (formerly LB54640), an investigational oral melanocortin-4 receptor (MC4R) agonist, in patients with acquired hypothalamic obesity.
Hypothalamic obesity is a…
This story appeared on benzinga.com, 2025-07-09 17:35:24.